menu
    • menu

    Company profile for Elegen

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Elegen is at the forefront of advancing the life sciences by offering distinctive perspectives and technical ingenuity to expedite the synthesis of high-quality synthetic DNA. The leadership team, boasting decades of experience in pioneering molecular biology, chemistry, and microfluidics, guides the company. Employing an exclusive microfluidics methodology, Elegen accelerates the construction of longer, superior-quality DNA w...
    Elegen is at the forefront of advancing the life sciences by offering distinctive perspectives and technical ingenuity to expedite the synthesis of high-quality synthetic DNA. The leadership team, boasting decades of experience in pioneering molecular biology, chemistry, and microfluidics, guides the company. Employing an exclusive microfluidics methodology, Elegen accelerates the construction of longer, superior-quality DNA within an efficient timeframe. This breakthrough technology is geared towards serving diverse industries, including agriculture, chemistry, healthcare, and pharmaceuticals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ElegenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Carlos, California 94070
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://elegenbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/elegenbio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ElegenBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Elegen Lowers Prices Across ENFINIA Synthetic DNA Portfolio
    Elegen Lowers Prices Across ENFINIA Synthetic DNA Portfolio

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127084367/en/Elegen-Raises-the-Bar-for-Synthetic-DNA-by-Lowering-Prices-Across-Its-ENFINIA-Portfolio

    BUSINESSWIRE
    27 Jan 2026
    Share Share
    Elegen Provides Early Access To Gen II Cell-Free DNA Platform
    Elegen Provides Early Access To Gen II Cell-Free DNA Platform

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028678992/en/Elegen-Offers-Early-Access-to-Gen-II-Cell-Free-DNA-Platform-Setting-New-Standards-for-Speed-Quality-and-Cost

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Elegen Enhances mRNA Synthesis Speed with ENFINIA™­ IVT Launch
    Elegen Enhances mRNA Synthesis Speed with ENFINIA™­ IVT Launch

    09 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-09/elegen-boosts-the-speed-and-reliability-of-mrna-synthesis-with-commercial-launch-of-enfinia-ivt-re

    PHARMAWEB
    09 Sep 2025
    Share Share
    Elegen, Nutcracker Therapeutics to Pilot Fully Cell-Free RNA
    Elegen, Nutcracker Therapeutics to Pilot Fully Cell-Free RNA

    11 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250711152688/en/Elegen-and-Nutcracker-Therapeutics-to-Pilot-First-Fully-Cell-Free-Manufacturing-Process-for-RNA-based-Personalized-Cancer-Therapeutics

    BUSINESSWIRE
    11 Jul 2025
    Share Share
    Elegen Adds IVT DNA to ENFINIA™ RNA Platform
    Elegen Adds IVT DNA to ENFINIA™ RNA Platform

    07 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250507743737/en/Elegen-Expands-ENFINIA-Platform-with-IVT-Ready-DNA-to-Streamline-RNA-Therapeutics-Development

    BUSINESSWIRE
    07 May 2025
    Share Share
    Elegen launches Enfina DNA enhancement for rapid synthesis of highly complex DNA
    Elegen launches Enfina DNA enhancement for rapid synthesis of highly complex DNA

    22 Mar 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/biotech/elegen-launches-enfina-dna-enhancement-for-rapid-synthesis-of-highly-complex-dna-15428

    INDIANPHARMAPOST
    22 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search